Rapid Release Gels, Arthritis Formulation Put Tylenol In US OTC Analgesic Lead
Executive Summary
Tylenol brand consumption grows 10% on sales of Rapid Release Gel and Tylenol Arthritis, reaching top spot among analgesic products in the US, J&J says. Retailers' inventory builds as a result of prior-year supply constraints driven by Hurricane Maria also helped drive growth.
You may also be interested in...
J&J Launches Neutrogena Bright Boost, Children's Tylenol Dissolve Packs
Neutrogena Bright Boost line launches with technology borrowed from J&J's recently acquired NeoStrata high-end skin care line, worldwide consumer health chief Thibaut Mongon says. J&J also launches Children’s Tylenol Dissolve Packs.
J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
Adding Zarbee's, J&J Gains Natural Market Footprint, Claims Credibility
Zarbee's Naturals vitamin, mineral and dietary supplement products were launched in 2008 by a physician interested in offering non-drug alternative remedies for children and adults for indications such as cough and cold, sore throat, immune support, sleep and digestive health. J&J on the other hand, has been challenged in class action litigation about natural claims it's used on some of its Aveeno and Neutgrogena skin care product labels.